126 related articles for article (PubMed ID: 2416568)
1. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
2. New SCM (structuredness of the cytoplasmatic matrix)-based approach in breast cancer detection.
Birindelli S; Colnaghi MI; Pilotti S
Tumori; 1996; 82(6):550-3. PubMed ID: 9061062
[TBL] [Abstract][Full Text] [Related]
3. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
[TBL] [Abstract][Full Text] [Related]
4. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
Cercek L; Cercek B; Franklin CI
Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
[TBL] [Abstract][Full Text] [Related]
5. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
6. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
Balding P; Light PA; Preece AW
Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
[TBL] [Abstract][Full Text] [Related]
7. Validation of the SCM-test for the diagnosis of cancer.
Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
Schnuda ND
Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
[TBL] [Abstract][Full Text] [Related]
9. [Specificity of lymphocytic reaction to tumor antigens--approaches to a cancer diagnosis in vitro?].
Muhrer KH
Fortschr Med; 1984 Jan; 102(3):45-8. PubMed ID: 6199270
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the SCM test for the diagnosis of cancer of the breast.
Chaitchik S; Deutsch M; Asher O; Krauss G; Lebovich P; Michlin H; Weinreb A
Eur J Cancer Clin Oncol; 1988 May; 24(5):861-6. PubMed ID: 3169091
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of the cellscan technique for the SCM test in breast cancer.
Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
[TBL] [Abstract][Full Text] [Related]
12. Determination of cell mediated immunity against tumour associated antigens in patients of ENT.
Nowak R; Günther M; Jenssen HL; Seyfarth M; Werner H; Putzke HP
Acta Otolaryngol; 1979; 87(3-4):400-3. PubMed ID: 87106
[TBL] [Abstract][Full Text] [Related]
13. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence polarisation changes in lymphocyte cytoplasm as a diagnostic test for breast carcinoma.
Ron IG; Deutsch M; Tirosh R; Weinreb A; Eisenthal A; Chaitchik S
Eur J Cancer; 1995 Jun; 31A(6):917-20. PubMed ID: 7646921
[TBL] [Abstract][Full Text] [Related]
15. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
[TBL] [Abstract][Full Text] [Related]
16. Preparation of a diagnostic antigen of human melanoma based on lymphocyte activation as measured by intracellular fluorescein fluorescence polarization.
Avtalion N; Avtalion R; Tirosh R; Sheinberg A; Weinreb A; Avinoach I; Deutsch M
Cancer Detect Prev; 1999; 23(1):64-71. PubMed ID: 9892992
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of polarizing luminescence in the study of changes in the cytoplasm of lymphocytes--SCM test].
Benes J
Sb Lek; 1984 Sep; 86(8-9):245-50. PubMed ID: 6209784
[No Abstract] [Full Text] [Related]
18. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
[TBL] [Abstract][Full Text] [Related]
19. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
Pritchard JA; Sutherland WH
Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
